gh55
Lymphoblastic Leukemia in Children
KK Women's and Children's HospitalPhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 33/ 100
- Competitive Position
- 95/ 100
Competitive context
4 Active assets in the Lymphoblastic Leukemia in Children cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Anti-Cd19 Car T-Cells KK Women's and Children's Hospital | Phase 2 | CCC |
gh21 KK Women's and Children's Hospital | Phase 1/2 | CCC |
Dalbavancin St. Jude Children's Research Hospital | Phase 1 | CC |
Levofloxacin Iv St. Jude Children's Research Hospital | Phase 1 | CC |
Same molecule, other indications
gh55 is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →